Gemander, Nicolas
Neumann, Julika
Veiga, Rafael
Etienne, Isabelle
Prezzemolo, Teresa
Kemlin, Delphine
Pannus, Pieter
Depickère, Stéphanie
Olislagers, Véronique
Vu Duc, Inès
Waegemans, Alexandra
Gerbaux, Margaux
Bücken, Leoni
Dahma, Hafid
Martin, Charlotte
Dauby, Nicolas
Goossens, Maria E.
Desombere, Isabelle
Roca, Carlos P.
Willemsen, Mathijs
Goriely, Stanislas
Le Moine, Alain
Marchant, Arnaud
Liston, Adrian
Humblet-Baron, Stephanie https://orcid.org/0000-0003-4684-069X
Funding for this research was provided by:
KU Leuven C1 program, the European Union’s Horizon 2020 research and innovation programme (No 874707 (EXIMIOUS), No 874707 (EXIMIOUS), No 874707 (EXIMIOUS), No 874707 (EXIMIOUS), No 874707 (EXIMIOUS), No 874707 (EXIMIOUS), No 874707 (EXIMIOUS), No 874707 (EXIMIOUS), No 874707 (EXIMIOUS), No 874707 (EXIMIOUS), No 874707 (EXIMIOUS), No 874707 (EXIMIOUS), No 874707 (EXIMIOUS), No 874707 (EXIMIOUS), No 874707 (EXIMIOUS), No 874707 (EXIMIOUS), No 874707 (EXIMIOUS), No 874707 (EXIMIOUS), No 874707 (EXIMIOUS), No 874707 (EXIMIOUS), No 874707 (EXIMIOUS), No 874707 (EXIMIOUS), No 874707 (EXIMIOUS), No 874707 (EXIMIOUS), No 874707 (EXIMIOUS))
Biotechnology and Biological Sciences Research Council (BBSRC) through Institute Strategic Program Grant funding (BBS/E/B/000C0427 and BBS/E/B/000C0428, BBS/E/B/000C0427 and BBS/E/B/000C0428, BBS/E/B/000C0427 and BBS/E/B/000C0428, BBS/E/B/000C0427 and BBS/E/B/000C0428, BBS/E/B/000C0427 and BBS/E/B/000C0428, BBS/E/B/000C0427 and BBS/E/B/000C0428, BBS/E/B/000C0427 and BBS/E/B/000C0428, BBS/E/B/000C0427 and BBS/E/B/000C0428, BBS/E/B/000C0427 and BBS/E/B/000C0428, BBS/E/B/000C0427 and BBS/E/B/000C0428, BBS/E/B/000C0427 and BBS/E/B/000C0428, BBS/E/B/000C0427 and BBS/E/B/000C0428, BBS/E/B/000C0427 and BBS/E/B/000C0428, BBS/E/B/000C0427 and BBS/E/B/000C0428, BBS/E/B/000C0427 and BBS/E/B/000C0428, BBS/E/B/000C0427 and BBS/E/B/000C0428, BBS/E/B/000C0427 and BBS/E/B/000C0428, BBS/E/B/000C0427 and BBS/E/B/000C0428, BBS/E/B/000C0427 and BBS/E/B/000C0428, BBS/E/B/000C0427 and BBS/E/B/000C0428, BBS/E/B/000C0427 and BBS/E/B/000C0428, BBS/E/B/000C0427 and BBS/E/B/000C0428, BBS/E/B/000C0427 and BBS/E/B/000C0428, BBS/E/B/000C0427 and BBS/E/B/000C0428, BBS/E/B/000C0427 and BBS/E/B/000C0428)
KU Leuven BOFZAP start-up grant
European Regional Development Fund (ERDF) of the Walloon Region (Wallonia-Biomed portfolio, 411132-957270, Wallonia-Biomed portfolio, 411132-957270, Wallonia-Biomed portfolio, 411132-957270, Wallonia-Biomed portfolio, 411132-957270, Wallonia-Biomed portfolio, 411132-957270, Wallonia-Biomed portfolio, 411132-957270, Wallonia-Biomed portfolio, 411132-957270, Wallonia-Biomed portfolio, 411132-957270, Wallonia-Biomed portfolio, 411132-957270, Wallonia-Biomed portfolio, 411132-957270, Wallonia-Biomed portfolio, 411132-957270, Wallonia-Biomed portfolio, 411132-957270, Wallonia-Biomed portfolio, 411132-957270, Wallonia-Biomed portfolio, 411132-957270, Wallonia-Biomed portfolio, 411132-957270, Wallonia-Biomed portfolio, 411132-957270, Wallonia-Biomed portfolio, 411132-957270, Wallonia-Biomed portfolio, 411132-957270, Wallonia-Biomed portfolio, 411132-957270, Wallonia-Biomed portfolio, 411132-957270, Wallonia-Biomed portfolio, 411132-957270, Wallonia-Biomed portfolio, 411132-957270, Wallonia-Biomed portfolio, 411132-957270, Wallonia-Biomed portfolio, 411132-957270, Wallonia-Biomed portfolio, 411132-957270)
Stichting Alzheimer Onderzoek - Fondation Recherche Maladie Alzheimer (SAO-FMA) and Stichting tegen Kanker (2020-106 and 2022-140, 2020-106 and 2022-140, 2020-106 and 2022-140, 2020-106 and 2022-140, 2020-106 and 2022-140, 2020-106 and 2022-140, 2020-106 and 2022-140, 2020-106 and 2022-140, 2020-106 and 2022-140, 2020-106 and 2022-140, 2020-106 and 2022-140, 2020-106 and 2022-140, 2020-106 and 2022-140, 2020-106 and 2022-140, 2020-106 and 2022-140, 2020-106 and 2022-140, 2020-106 and 2022-140, 2020-106 and 2022-140, 2020-106 and 2022-140, 2020-106 and 2022-140, 2020-106 and 2022-140, 2020-106 and 2022-140, 2020-106 and 2022-140, 2020-106 and 2022-140, 2020-106 and 2022-140)
Article History
Received: 16 October 2024
Accepted: 2 June 2025
First Online: 1 July 2025
Competing interests
: The authors declare no competing interests.